The Stem Cell Podcast

Ep. 73: “Bench to Big Business” Featuring Dr. Allen Eaves

Aug 30, 2016
Dr. Allen Eaves, a physician-scientist and CEO of STEMCELL Technologies, shares his transformative journey from a bench scientist to a biotech entrepreneur. He discusses how his early work in hematopoiesis led to product innovations and the founding of his successful company. Allen highlights the differences between academic research and running a biotech business, emphasizing the importance of quality and strategic growth. He also offers practical advice for scientists looking to make similar career transitions, blending humor with insightful anecdotes.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

From Marine Dreams To CML Breakthroughs

  • Allen Eaves described shifting from marine biology plans to medicine, then cancer research and bone marrow transplants.
  • He and his team developed culture-purging methods that enabled autologous transplants for CML patients.
ANECDOTE

Bootstrapping A Reagent Business

  • Eaves explained how selling optimized media and purified erythropoietin funded research and recruitment.
  • Early product sales grew quickly and seeded what became STEMCELL Technologies.
INSIGHT

Business Frees Scientists From Academic Limits

  • Running a company removed many resource constraints he faced in academia and let him focus on product quality.
  • That freedom shifted his challenge to making consistently superior reagents and service.
Get the Snipd Podcast app to discover more snips from this episode
Get the app